From Ethical Review to Governance Oversight: A PMI-CPMAI Model for Healthcare AI Projects and Programs

Authors

  • Mashaer Mohammed AlSereidi Hamdan bin Mohamad Smart University
  • Huda Salem Alshehhi Hamdan bin Mohamad Smart University
  • Aalaa Ahmed AlMenhali Hamdan bin Mohamad Smart University
  • Mounir El Khatib Hamdan bin Mohamad Smart University

DOI:

https://doi.org/10.54489/ijbas.v6i1.596

Keywords:

AI ethics, healthcare governance, ethical committees, project governance, PMI-CPMAI, qualitative research

Abstract

This article examines how AI ethics committees can be integrated into healthcare project governance using a PMI-CPMAI aligned oversight model. In this study, ethics refers to the governance of fairness, transparency, accountability, patient safety, and responsible decision-making in healthcare AI systems.The topic matters because healthcare organisations are increasingly using AI in areas such as risk prediction, monitoring, scheduling, and clinical decision support, yet ethical oversight often remains weak, late, or unclear. The study used a qualitative approach and drew on four semi-structured interview responses collected from healthcare professionals in management and clinical roles. The findings show an uneven picture. Some respondents reported the presence of an ethics committee, while others did not. Even where some form of oversight existed, authority was often advisory, escalation routes were weak, and monitoring after deployment was inconsistent. Respondents also pointed to practical obstacles such as the absence of clear policy, limited AI understanding among reviewers, and low involvement of frontline staff. The article argues that healthcare organisations need more than broad ethical awareness. They need a clearer governance arrangement that places ethical review inside project stages, decision gates, accountability structures, and post-deployment follow-up. A PMI-CPMAI aligned oversight model offers a practical route for doing this by placing governance, validation, and lifecycle control within the management of AI initiatives rather than treating ethics as a separate compliance exercise (Project Management Institute, 2023).

References

Davis, F. D. (1989). Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly, 13(3), 319–340. https://doi.org/10.2307/249008

McKay, F., Kwon, J., & Smith, T. (2023). Ethical oversight and governance challenges in artificial intelligence healthcare research. Journal of Medical Ethics. (Verify volume, issue, and pages.)

Organisation for Economic Co-operation and Development. (2019). OECD principles on artificial intelligence. OECD Publishing. https://oecd.ai

Project Management Institute. (2023). Cognitive Project Management for AI (CPMAI) methodology guide. Project Management Institute.

Shaw, D., Elger, B., & Colledge, F. (2024). Research ethics governance for artificial intelligence in healthcare. BMC Medical Ethics. (Verify volume, issue, and pages.)

U.S. Food and Drug Administration. (2025). Artificial intelligence-enabled device software functions: Lifecycle management and marketing submission recommendations. U.S. Department of Health and Human Services. (Draft guidance document.)

Wang, F., Kaushal, R., & Khullar, D. (2023). Standards, regulation, and governance of artificial intelligence in medicine: A systematic review. npj Digital Medicine, 6(1). (Verify article number and pages.)

World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. World Health Organization.

Downloads

Published

2026-06-23

How to Cite

From Ethical Review to Governance Oversight: A PMI-CPMAI Model for Healthcare AI Projects and Programs. (2026). International Journal of Business Analytics and Security (IJBAS), 6(1), 48-60. https://doi.org/10.54489/ijbas.v6i1.596

Similar Articles

61-70 of 90

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 > >>